Theratechnologies (TSE:TH) Shares Cross Above 50-Day Moving Average – Here’s Why

Theratechnologies Inc. (TSE:THGet Free Report)’s stock price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$1.74 and traded as high as C$1.85. Theratechnologies shares last traded at C$1.75, with a volume of 78,408 shares.

Theratechnologies Stock Down 0.6 %

The stock has a market cap of C$80.01 million, a price-to-earnings ratio of -9.67, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73. The firm’s fifty day moving average price is C$1.74 and its two-hundred day moving average price is C$1.83. The company has a debt-to-equity ratio of 562.07, a current ratio of 1.10 and a quick ratio of 0.64.

Theratechnologies (TSE:THGet Free Report) last announced its quarterly earnings results on Thursday, October 10th. The company reported C$0.09 earnings per share (EPS) for the quarter. Theratechnologies had a negative return on equity of 1,116.86% and a negative net margin of 8.47%. The business had revenue of C$30.96 million for the quarter. Sell-side analysts forecast that Theratechnologies Inc. will post 0.0298643 earnings per share for the current fiscal year.

Theratechnologies Company Profile

(Get Free Report)

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.

See Also

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.